Status:
ACTIVE_NOT_RECRUITING
Testing YAG Laser Iridotomy for Primary Angle-Closure Glaucoma
Lead Sponsor:
Isfahan University of Medical Sciences
Conditions:
Glaucoma Eye
Angle Closure Glaucoma
Eligibility:
All Genders
24+ years
Phase:
NA
Brief Summary
This study evaluates the effectiveness and safety of YAG laser peripheral iridotomy performed at two different locations (temporal and inferior) in patients with primary angle-closure glaucoma, a lead...
Eligibility Criteria
Inclusion
- Diagnosis of Primary Angle-Closure Glaucoma.
- Adults (typically over 40 years old).
- Ability to provide informed consent.
- Narrow or closed anterior chamber angle (based on gonioscopy).
- Intraocular pressure (IOP) controlled with medication but requiring surgery.
- No previous iridotomy.
Exclusion
- econdary glaucoma.
- Active eye diseases (e.g., infection or inflammation).
- Advanced cataracts or lens-related issues.
- Severe visual impairment (e.g., less than 20/200 vision).
- Uncontrolled systemic diseases (e.g., diabetes or cardiovascular disease).
- Pregnancy or breastfeeding.
- Previous eye surgery (except for minor procedures).
- Inability to follow-up with scheduled visits.
- \-
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT07195370
Start Date
May 1 2025
End Date
January 1 2026
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Isfahan University of Medical Sciences
Isfahan, Isfahan, Iran, 0098